Intervention not reported
Compliance with treatment · people with fungal ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment discontinuation · women with high‐grade VIN
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with IOP control (higher number of events is better) · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
Phacoemulsification may leads to higher proportion of participants with IOP control (higher number of events… compared with laser peripheral iridotomy (low certainty).
1 finding from 1 review
Proportion of participants requiring further IOP‐lowering interventions (additional surgery, medications, or both) (lower number of events is better) · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
It is very uncertain whether phacoemulsification changes proportion of participants requiring further IOP‐lowering… compared with laser peripheral iridotomy (very low certainty).
1 finding from 1 review
Proportion of participants with 1 or more recurrent APAC episodes in the same eye (lower number of events is better) · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
It is very uncertain whether phacoemulsification changes proportion of participants with 1 or more recurrent APAC episodes in… compared with laser peripheral iridotomy (very low certainty).
1 finding from 1 review
Mean number of antiglaucoma medications at 1‐year · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Mean IOP ( · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Mean change in angle findings, measured by any method · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Adverse effects · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Death at 6 to 12 months · malignant cerebral oedema after ischaemic stroke
Summary of findings table ‐ surgical decompression leads to lower death at 6 to 12 months compared with medical treatment alone (high certainty).
1 finding from 1 review
Death or severe disability (mRS > 4) at 6 to 12 months · malignant cerebral oedema after ischaemic stroke
Summary of findings table ‐ surgical decompression leads to lower death or severe disability (mRS > 4) at 6 to 12 months compared with medical treatment alone (high certainty).
1 finding from 1 review
Death or moderate disability (mRS > 3) at 6 to 12 months · malignant cerebral oedema after ischaemic stroke
Summary of findings table ‐ surgical decompression probably leads to lower death or moderate disability (mRS > 3) at 6 to 12 months compared with medical treatment alone (moderate certainty).
1 finding from 1 review
Severe disability (mRS = 5) at 6 to 12 months · malignant cerebral oedema after ischaemic stroke
Summary of findings table ‐ surgical decompression showed no clear difference in severe disability (mRS = 5) at 6 to 12 months compared with medical treatment alone (low certainty).
1 finding from 1 review
Adverse events · malignant cerebral oedema after ischaemic stroke
1 finding from 1 review
Hydrocephalus · malignant cerebral oedema after ischaemic stroke
1 finding from 1 review
Reoperation · malignant cerebral oedema after ischaemic stroke
1 finding from 1 review
Complete recovery of facial nerve function at 12 months Defined as: complete recovery HB grade I. · Bell's palsy
It is very uncertain whether surgery for Bell's palsy changes complete recovery of facial nerve function at 12 months Defined as:… compared with medical treatment (oral prednisolone) or no treatment (very low certainty).
1 finding from 1 review
Pain frequency and intensity (measured as part of the 0‐500 point IBS‐SSS questionnaire) · people with inflammatory bowel disease
1 finding from 1 review
Withdrawals due to adverse events · people with inflammatory bowel disease
1 finding from 1 review
Abdominal pain frequency or change in frequency · people with inflammatory bowel disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found